Reaction
Contraindicated Product Prescribed reporting signals
As of the last recalculation, Contraindicated Product Prescribed appears in 1,649 FAERS reports alongside 28 co-occurring drug terms. The strongest observed disproportionality signal is DUTASTERIDE (PRR 125.3).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Dutasteride | 77 | 125.3 | 126.5 |
| Naltrexone Hydrochloride And Bupropion Hydrochloride | 50 | 76.3 | 76.7 |
| Nirmatrelvir And Ritonavir | 129 | 32.5 | 32.6 |
| Dalteparin Sodium | 17 | 20.5 | 20.5 |
| Suvorexant | 17 | 16.7 | 16.7 |
| Itraconazole | 15 | 16.4 | 16.4 |
| Clarithromycin | 35 | 13.1 | 13.1 |
| Nitrofurantoin | 15 | 11.6 | 11.6 |
| Nitrofurantoin (Monohydrate/Macrocrystals) | 15 | 11.4 | 11.4 |
| Dofetilide | 9 | 10.9 | 10.9 |
| Terbinafine Hydrochloride | 7 | 10.0 | 10.0 |
| Vortioxetine | 13 | 9.7 | 9.7 |
| Naltrexone | 23 | 9.5 | 9.5 |
| Fluticasone Furoate | 9 | 9.4 | 9.4 |
| Oxymorphone Hydrochloride | 7 | 7.6 | 7.6 |
| Umeclidinium Bromide And Vilanterol Trifenatate | 9 | 6.8 | 6.8 |
| Desoximetasone | 10 | 6.7 | 6.7 |
| Guanfacine | 4 | 6.4 | 6.4 |
| Pitavastatin Calcium | 5 | 6.2 | 6.2 |
| Rasagiline Mesylate | 5 | 5.7 | 5.7 |
| Sevelamer Carbonate | 5 | 5.5 | 5.5 |
| Fluticasone Furoate, Umeclidinium Bromide And Vilanterol Trifenatate | 17 | 5.2 | 5.2 |
| Dronedarone | 4 | 5.0 | 5.0 |
| Cabotegravir | 3 | 4.7 | 4.7 |
| Tolvaptan | 5 | 4.4 | 4.4 |
| Siponimod | 3 | 4.3 | 4.3 |
| Dalfampridine | 23 | 4.1 | 4.1 |
| Crizotinib | 3 | 3.0 | 3.0 |